In summary, this study elaborated on the promoting effect of MYL6B in rectal adenocarcinoma progression, thus providing novel insight for strategies of clinical diagnosis and drug application in the future clinical study. The gene discussed is MYL6B; the disease is rectum adenocarcinoma.